Romanian Agency Reorganizes To Boost Performance & Face Brexit Challenge
Executive Summary
The Romanian medicines agency is to be reorganized to improve the way it works and allow it to take on more work as a result of Brexit. One consequence is that industry fees may have to rise to pay for this work as well as a sharp rise in staff numbers.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.